<<
>>

CONCLUSIONS:

1. Appointment GIBP (etanertsepta, abatatsepta, infliksimaba) is shown all children with JUIA, not answering standard antirheumatic therapy (the answer to therapy

<< | >>
Scientific source Loskutova Olga Jurevna. Efficiency and safety of genno-engineering biological preparations (infliksimab, etanertsept, abatatsept) at children with various variants juvenilnogo an idiopathic arthritis. The DISSERTATION on competition of a scientific degree of the candidate of medical sciences. Moscow - 2014. 2014

Скачать оригинал источника

Other medical related information CONCLUSIONS::

  1. CONCLUSIONS
  2. Conclusions
  3. CONCLUSIONS:
  4. CONCLUSIONS
  5. CONCLUSIONS
  6. CONCLUSIONS
  7. CONCLUSIONS
  8. Conclusions:
  9. CONCLUSIONS
  10. CONCLUSIONS
  11. CONCLUSIONS
  12. Chapter 4 the Conclusion
  13. Conclusions
  14. CONCLUSIONS
  15. CONCLUSIONS
  16. CONCLUSIONS:
  17. THE CONCLUSION
  18. THE CONCLUSION
  19. THE CONCLUSION